药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Forasartan
Metreleptin
The metabolism of Idelalisib can be increased when combined with Metreleptin.
Forasartan
Tofacitinib
The metabolism of Tofacitinib can be decreased when combined with Idelalisib.
Forasartan
Iloperidone
The metabolism of Iloperidone can be decreased when combined with Idelalisib.
Forasartan
Ibrutinib
The metabolism of Ibrutinib can be decreased when combined with Idelalisib.
Forasartan
Armodafinil
The metabolism of Idelalisib can be increased when combined with Armodafinil.
Forasartan
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Idelalisib.
Forasartan
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Idelalisib.
Forasartan
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Idelalisib.
Forasartan
Roflumilast
Roflumilast may increase the immunosuppressive activities of Idelalisib.
Forasartan
Siponimod
The risk or severity of adverse effects can be increased when Idelalisib is combined with Siponimod.
Forasartan
Melengestrol
The risk or severity of adverse effects can be increased when Idelalisib is combined with Melengestrol.
Forasartan
Fluprednisolone
The risk or severity of adverse effects can be increased when Idelalisib is combined with Fluprednisolone.
Forasartan
Ruxolitinib
The risk or severity of adverse effects can be increased when Idelalisib is combined with Ruxolitinib.
Forasartan
Trabectedin
The risk or severity of adverse effects can be increased when Idelalisib is combined with Trabectedin.
Forasartan
Thiotepa
The risk or severity of adverse effects can be increased when Idelalisib is combined with Thiotepa.
Forasartan
Bleselumab
The risk or severity of adverse effects can be increased when Idelalisib is combined with Bleselumab.
Forasartan
Rozanolixizumab
The risk or severity of adverse effects can be increased when Idelalisib is combined with Rozanolixizumab.
Forasartan
Risankizumab
The risk or severity of adverse effects can be increased when Idelalisib is combined with Risankizumab.
Forasartan
Monomethyl fumarate
The risk or severity of adverse effects can be increased when Idelalisib is combined with Monomethyl fumarate.
Forasartan
Tetrandrine
The risk or severity of adverse effects can be increased when Idelalisib is combined with Tetrandrine.